POLONEZ BIS-3 – effects of tyrosine kinase inhibitors on endothelium

We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: “Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier integrity“, under funding from the POLONEZ BIS-3 programme.

POLONEZ BIS is co-funded by the European Commission and the Polish National Science Centre under the Marie Skłodowska-Curie COFUND grant. In three calls, the programme recruited over 120 experienced researchers from all over the world. They will move to Poland for 24 months to conduct their basic research in public or private institutions of their choice.

(more…)

RESULTS OF THE THIRD COMPETITION FOR WIB RESEARCH TEAM ARE ANNOUNCED

With undisguised enthusiasm, we would like to share with you the good news. After a long period of waiting for the results of the competition for the selection of Research Teams conducting scientific activities in the form of a Virtual Research Institute, we have received a positive recommendation for the funding of the project “Personalized endothelial diagnostics in anticancer treatment; towards modern vasculo-oncology” [Acronym: ADEVASCO].

Once again in recent years, Professor Stefan Chłopicki, director of JCET, will head an interdisciplinary research group carrying out a project in the area of endothelial biomedicine. The ADEVASCO project, led by the Jagiellonian University, involves five other institutions in Poland (Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences in Olsztyn, Medical University of Gdańsk, Maria Skłodowska-Curie National Institute of Oncology – National Research Institute, Warsaw University of Technology). The WIB research team of the ADEVASCO project will be formed with the participation of scientists from these 6 units with complementary research and clinical expertise necessary for this ambitious project. The signing of the project agreement, the official start of the project and the communication of more details about this project are planned for September 2024.   

(more…)